NCT04844125View on ClinicalTrials.gov

SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

PHASE3CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions

Primary Hypercholesterolemia

Interventions

DRUG

SHR-1209

SHR-1209

DRUG

SHR-1209 Placebo

SHR-1209 Placebo

Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY